Navigation Links
Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

anderbilt-Ingram Cancer Center, Nashville, TN

-- Abstract #5011, Clinical Science Symposium, Saturday, May 31, 2008,

2:15 - 2:30 p.m., W375e

Lung Cancer

-- A randomized discontinuation Phase II study of sorafenib vs placebo in

patients with non-small cell lung cancer who have failed at least two

prior chemotherapy regimens

-- Joan Schiller, MD, professor and chief of the Hematology/Oncology

Division at University of Texas Southwestern and Andrea L. Simmons

Distinguished Chair in Cancer Research, Dallas, TX

-- Abstract #8014, Monday, June 2, 4 - 4:15 p.m., W375e

-- A Phase II trial of BAY 43-9006 in patients with platinum treated

extensive stage small cell lung cancer (E-SCLC): A SWOG (SO435) Phase

II trial

-- Barbara Gitlitz, MD, associate professor of clinical, director,

Lung, Head and Neck Program, USC/Norris Comprehensive Cancer Center,

Los Angeles, CA

-- Poster 20, abstract #8039, poster discussion, Monday, June 2, 2008,

12 - 1 p.m., W375d

Solid Tumors

-- A drug interaction study of sorafenib and rapamycin in patients with

advanced malignancies

-- Tara Gangadhar, MD, fellow, University of Chicago, Chicago, IL

-- Poster 10A, abstract #2545, poster discussion, Sunday, June 1, 2008,

2 - 6 p.m., S Hall A1

-- A phase II study: Combination of sorafenib with docetaxel and cisplatin

in the treatment of metastatic or advanced unresectable gastric and

gastroesophageal junction (GEJ) adenocarcinoma (ECOG 5203)

-- Weijing Sun, MD, assistant professor of medicine, University of

Pennsylvania (Philadelphia, PA) director of Upper GI and

Pancreatic-biliary-hepatic Cancer Group and the associate director

of the GI Cancer Program

-- Poster 23, abstract #4535, poster discussion, Tu
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Bayer CropSciences Vegetable Seed Business Nunhems Acquires US Lettuce Seed Company Paragon Seed
2. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
3. Indevus Comments on Bayer Healthcare Discontinuation of Viadur(R)
4. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
5. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
6. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
7. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... NEW BRUNSWICK , Nueva Jersey , 22 ... Award for Biomedical Research abre hoy su llamada ... las personas cuya investigación científica ha hecho, o tiene ... de la salud humana. Las nominaciones se aceptarán hasta ...
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
(Date:12/24/2014)... SPRING, Md. , Dec. 24, 2014  United Therapeutics ... Medtronic, Inc. (NYSE: MDT ) has submitted ... Drug Administration (FDA) for the use of Medtronic,s SynchroMed ... newly developed catheter) for use with United Therapeutics, Remodulin ...
(Date:12/24/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade hypothermic storage and cryopreservation freeze ... and tissues  ("BioLife" or the "Company"), today announced that it ... 4, 2015 (the "Annual Meeting"). Because the expected ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... May 26, 2011 PAREXEL International Corporation (NASDAQ: ... today announced that it has been selected as one ... clinical development services. PAREXEL will work with ... its clinical development programs while delivering a high level ...
... NEW YORK, May 26, 2011 ... market research report is available ... Technology Transfer Strategies - ... Within the Pharmaceutical and Biopharmaceutical ...
... what differentiates cancer cells from normal cells is limited by ... of individual cells. By combing two different methods, a team ... a tool for studying signal paths on several levels at ... PLoS One . "We also show that the ...
Cached Biology Technology:Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development 2Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development 3Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development 4Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development 5Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 2Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 3Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 4Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 5Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 6Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 7Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 8Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries 9Combo method reveals cells' signal systems 2
(Date:1/22/2015)... , January 22, 2015 , ... year  The European Patent Office to present a video ... British nominations to be featured: Christofer Toumazou and ... former finalists and winners of the Award   Starting ...
(Date:1/22/2015)... YORK , Jan. 22, 2015   EyeLock, Inc. , ... it has appointed Steve Gerber to the new ... will be responsible for leading development of mobile platforms and ... years of success and innovation in the semiconductor industry to ...
(Date:12/24/2014)... Dec. 23, 2014  Since its launch in December 2014, the ... the pain of trying to remember their usernames and passwords ... to their smartphones. To assist people who have struggled to ... that created 1U and focuses on redefining identity, announced today ...
Breaking Biology News(10 mins):Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3
... fruit and vegetable crops rely on pollination by bees and ... those species is uncertain. Now researchers from North Carolina State ... performance of pollinator species in order to determine which species ... "Widespread concerns over the fate of honey bees and other ...
... Bumblebees look cute. They have a thick fur, fly ... wasps. They are very much appreciated by farmers as ... crisis-stricken honeybee populations, the buff-tailed bumblebee, Bombus terrestris ... the pollination of fruit and vegetable crops both inside ...
... London, December 9, 2013 The world is still underfunding ... in ensuring comprehensive and equitable health care for all, and ... gender equality fit in? Papers in the latest ... recent history of sexual and reproductive health and rights at ...
Cached Biology News:Researchers develop system for assessing how effective species are at pollinating crops 2Peaceful bumblebee becomes invasive 2Peaceful bumblebee becomes invasive 3Reproductive Health Matters announces publication of its latest themed issue: New development paradigm 2
MOUSE ANTI HUMAN COMPLEMENT SC5B-9...
Human VEGF R Phycoerythrin Sampler (Cl 89106, 49560, 54733)...
ANTI ALPHA FSH:B...
... serum is collected from fasted mixed breed, mixed ... Available Anticoagulants: N-02: Citrate ... N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: ...
Biology Products: